Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Clinicopathological roles of S100A8 and S100A9 in cutaneous squamous cell carcinoma in vivo and in vitro.

Choi DK, Li ZJ, Chang IK, Yeo MK, Kim JM, Sohn KC, Im M, Seo YJ, Lee JH, Kim CD, Lee Y.

Arch Dermatol Res. 2014 Jul;306(5):489-96. doi: 10.1007/s00403-014-1453-y. Epub 2014 Feb 19.

PMID:
24550082
[PubMed - in process]
2.

S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.

Lee Y, Jang S, Min JK, Lee K, Sohn KC, Lim JS, Im M, Lee HE, Seo YJ, Kim CD, Lee JH.

Biochem Biophys Res Commun. 2012 Jul 13;423(4):647-53. doi: 10.1016/j.bbrc.2012.05.162. Epub 2012 Jun 7.

PMID:
22683330
[PubMed - indexed for MEDLINE]
3.

S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.

Duan L, Wu R, Ye L, Wang H, Yang X, Zhang Y, Chen X, Zuo G, Zhang Y, Weng Y, Luo J, Tang M, Shi Q, He T, Zhou L.

PLoS One. 2013 Apr 26;8(4):e62092. doi: 10.1371/journal.pone.0062092. Print 2013. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/61e0cb2d-6d8c-41d7-99f2-d1b97581e207.

PMID:
23637971
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Autocrine pathways involving S100A8 and/or S100A9 that are postulated to regulate the immunological functions of macrophages in rats.

Okada K, Arai S, Nakase H, Kohno H, Nakamura F, Takeda M, Toda Y, Itoh H, Adachi S, Ikemoto M.

Biochem Biophys Res Commun. 2015 Jan 2;456(1):415-20. doi: 10.1016/j.bbrc.2014.11.099. Epub 2014 Dec 6.

PMID:
25485702
[PubMed - in process]
5.

S100A9 has a protective role in inflammation-induced skin carcinogenesis.

McNeill E, Hogg N.

Int J Cancer. 2014 Aug 15;135(4):798-808. doi: 10.1002/ijc.28725. Epub 2014 Jan 28.

PMID:
24436096
[PubMed - indexed for MEDLINE]
6.

Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities.

Xu X, Wu WY, Tu WZ, Chu HY, Zhu XX, Liang MR, Xue Y, Wang JC, Zou HJ.

Clin Rheumatol. 2013 Oct;32(10):1501-10. doi: 10.1007/s10067-013-2305-4. Epub 2013 Jun 11.

PMID:
23754244
[PubMed - indexed for MEDLINE]
7.

Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.

Ang CW, Nedjadi T, Sheikh AA, Tweedle EM, Tonack S, Honap S, Jenkins RE, Park BK, Schwarte-Waldhoff I, Khattak I, Azadeh B, Dodson A, Kalirai H, Neoptolemos JP, Rooney PS, Costello E.

Carcinogenesis. 2010 Sep;31(9):1541-51. doi: 10.1093/carcin/bgq137. Epub 2010 Jul 9.

PMID:
20622003
[PubMed - indexed for MEDLINE]
Free Article
8.

S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue.

Li J, Riau AK, Setiawan M, Mehta JS, Ti SE, Tong L, Tan DT, Beuerman RW.

Mol Vis. 2011;17:2263-71. Epub 2011 Aug 20.

PMID:
21897749
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.

Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D.

Exp Cell Res. 2006 Jan 15;312(2):184-97. Epub 2005 Nov 17.

PMID:
16297907
[PubMed - indexed for MEDLINE]
10.

Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: a variety of functional roles of the two proteins as regulators in acute inflammatory reaction.

Koike A, Arai S, Yamada S, Nagae A, Saita N, Itoh H, Uemoto S, Totani M, Ikemoto M.

Inflammation. 2012 Apr;35(2):409-19. doi: 10.1007/s10753-011-9330-8.

PMID:
21487906
[PubMed - indexed for MEDLINE]
11.

S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma.

Ito Y, Arai K, Nozawa R, Yoshida H, Hirokawa M, Fukushima M, Inoue H, Tomoda C, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A.

Anticancer Res. 2009 Oct;29(10):4157-61.

PMID:
19846966
[PubMed - indexed for MEDLINE]
Free Article
12.

High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma.

Funk S, Mark R, Bayo P, Flechtenmacher C, Grabe N, Angel P, Plinkert PK, Hess J.

Int J Cancer. 2014 Oct 10. doi: 10.1002/ijc.29262. [Epub ahead of print]

PMID:
25302747
[PubMed - as supplied by publisher]
13.

Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells.

Yong HY, Moon A.

Arch Pharm Res. 2007 Jan;30(1):75-81.

PMID:
17328245
[PubMed - indexed for MEDLINE]
14.

Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.

Cormier K, Harquail J, Ouellette RJ, Tessier PA, Guerrette R, Robichaud GA.

Anticancer Agents Med Chem. 2014 Jan;14(1):35-45.

PMID:
24041228
[PubMed - indexed for MEDLINE]
15.

Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation.

Berthier S, Nguyen MV, Baillet A, Hograindleur MA, Paclet MH, Polack B, Morel F.

PLoS One. 2012;7(7):e40277. doi: 10.1371/journal.pone.0040277. Epub 2012 Jul 10.

PMID:
22808130
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.

Gebhardt C, Breitenbach U, Tuckermann JP, Dittrich BT, Richter KH, Angel P.

Oncogene. 2002 Jun 20;21(27):4266-76.

PMID:
12082614
[PubMed - indexed for MEDLINE]
Free Article
17.

S100A8 and S100A9 in inflammation and cancer.

Gebhardt C, Németh J, Angel P, Hess J.

Biochem Pharmacol. 2006 Nov 30;72(11):1622-31. Epub 2006 Jul 17. Review.

PMID:
16846592
[PubMed - indexed for MEDLINE]
18.

S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.

McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS, Geczy CL.

J Biol Chem. 2005 Dec 16;280(50):41521-9. Epub 2005 Oct 10.

PMID:
16216873
[PubMed - indexed for MEDLINE]
Free Article
19.

Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.

Grebhardt S, Veltkamp C, Ströbel P, Mayer D.

Int J Cancer. 2012 Dec 15;131(12):2785-94. doi: 10.1002/ijc.27591. Epub 2012 May 8.

PMID:
22505354
[PubMed - indexed for MEDLINE]
20.

S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.

Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R.

Curr Cancer Drug Targets. 2008 Jun;8(4):243-52.

PMID:
18537548
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk